⏱️60 Seconds $ARN $MRNA $SBUX ☕️ $DNKG $ABBV $WBA $NKLA see you on 📺 and @3at3_UOA more at @MarketRebels 🏴‍☠️

<p>60 Seconds you need to know before you go Jon Najarian Here, take a look at Moderna. Why because they are starting trials on children as young as six months to 12 months. And also take a look at AstraZeneca because even though a number of European countries have basically shut down the AstraZeneca COVID vaccine, nonetheless, they are getting an endorsement in Canada for people 65 and older Starbucks coffee chain up about 2% in the pre market, we just had the retail sales numbers, and they were not good. But the revision to January was exceedingly good took it up to 7.6%. Remember that including those stimulus checks and they were spent like that. In January apparently Walgreens Boots Alliance, sued by the Arkansas Attorney General, I've got ABBV The drug makers is going to be selling a portfolio of vias of women's drugs worth about $5 billion. So that's money and take a look at DraftKings they upsize their debt offering shares are up 2% in the pre. And let me give you one more. Take a look at Nicola NKLA down about 3% in the pre looks like they filed $100 million secondary offering. I am Jon Najarian. I will be on the Halftime Report today, as well as three and three. Make sure you tune into both. I'll see you then BANG!</p>